Reference assays for Clostridium difficile infection: one or two gold standards?

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Diagnostic Assays

Background:

• Accurate diagnosis of Clostridium difficile infection (CDI) is vital for effective treatment and control.
• Current reference assays, cell cytotoxicity assay (CCTA) and toxigenic culture (TC), detect different targets (toxins vs. toxigenic bacteria).
• Discrepancies between CCTA and TC highlight challenges in CDI diagnosis and the clinical significance of detecting toxigenic C. difficile without detectable toxins.

Purpose of the Study:

• To evaluate the diagnostic performance of reference assays for Clostridium difficile infection (CDI).
• To address the imperfect agreement between cell cytotoxicity assay (CCTA) and toxigenic culture (TC).
• To investigate factors influencing the performance of rapid diagnostic tests for CDI.

Main Methods:

• Comparison of cell cytotoxicity assay (CCTA) and toxigenic culture (TC) for Clostridium difficile diagnosis.
• Evaluation of reference assays used to determine the accuracy of alternative diagnostic tests.
• Analysis of discrepancies between tests detecting toxins versus toxigenic C. difficile.

Main Results:

• Cell cytotoxicity assay (CCTA) and toxigenic culture (TC) show imperfect agreement due to detecting different targets.
• A positive toxigenic culture (TC) indicates potential infectiousness and allows for isolate typing and susceptibility testing.
• Suboptimal performance of rapid diagnostic tests for CDI is partly due to issues in comparing methods with appropriate standards.

Conclusions:

• Further research is needed to improve understanding of routine diagnostic tests for CDI.
• Clarifying the clinical significance of detecting toxigenic C. difficile without free toxins is crucial.
• Standardizing comparison methods is essential for accurate evaluation of CDI diagnostic tests.